Stocks · Health care · Pharmaceutical Preparations

Abbott Laboratories

ABT Clue Score62
United States Fiscal year ends December CIK 0000001800 Results filed 21 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Daniel J Starks
26 Oct 2023
Director
Sold on a plan
23,093
$94.33
$2.18M
Daniel J Starks
26 Oct 2023
Director
Sold on a plan
26,907
$93.81
$2.52M
Daniel J Starks
27 Jul 2023
Director
Sold on a plan
29,066
$114.01
$3.31M
Daniel J Starks
27 Jul 2023
Director
Sold on a plan
20,934
$113.43
$2.37M
Philip P Boudreau
16 Jun 2023
Vice President
Sold on a plan
8,000
$106.00
$848.00K
Showing 250 of 1,360 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 916
Amendments (4/A) skipped 6
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 384
Sales at will 719
Transactions with no price 0
Shares from compensation/vesting 17,573,242
Sales filed before the plan box existed 692
History held since 3 Oct 2006